Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Sleep Medicine

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.sleep.2017.11.1134PMID 29458749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla.

  2016cited by this paper
• Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.

  2016cited by this paper
• A Novel Model for Brain Iron Uptake: Introducing the Concept of Regulation

  2015cited by this paper
• Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function.

  2015cited by this paper
• A comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndrome

  2015cited by this paper
• Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

  2014cited by this paper
• Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations

  2014cited by this paper
• Diurnal variations in brain iron concentrations in BXD RI mice.

  2014cited by this paper
• Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

  2014cited by this paper
• Lower molecular weight intravenous iron dextran for restless legs syndrome.

  2013cited by this paper
• Systems genetic analysis of the effects of iron deficiency in mouse brain

  2012cited by this paper
• The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index

  2012cited by this paper
• Investigating the response to intravenous iron in restless legs syndrome: an observational study.

  2012cited by this paper
• Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.

  2011cited by this paper
• The Reliability and Validity of the Korean Versions of the International Restless Legs Scale and the Restless Legs Syndrome Quality of Life Questionnaire

  2010cited by this paper
• Intravenous iron dextran for severe refractory restless legs syndrome.

  2010cited by this paper
• Restless legs syndrome: understanding its consequences and the need for better treatment.

  2010cited by this paper
• A randomized, double‐blind, placebo controlled, multi‐center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome

  2009cited by this paper
• Systems genetics analysis of iron regulation in the brain.

  2009cited by this paper
• A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome.

  2009cited by this paper
• Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.

  2009cited by this paper
• Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• The Reliability and Validity of the Korean Version of Paradigm of Questions for Epidemiology Studies of Restless Legs Syndrome and the Johns Hopkins Telephone Diagnostic Interview Form for the Restless Legs Syndrome.

  2007cited by this paper
• MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.

  2006cited by this paper
• Iron absorption by healthy women is not associated with either serum or urinary prohepcidin.

  2006cited by this paper
• CSF iron, ferritin and transferrin levels in restless legs syndrome

  2005cited by this paper
• Validation of the Restless Legs Syndrome Quality of Life questionnaire.

  2005cited by this paper
• Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea.

  2004cited by this paper
• The treatment of restless legs syndrome with intravenous iron dextran.

  2004cited by this paper
• Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

  2003cited by this paper
• Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

  2000cited by this paper
• A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome

  2000cited by this paper
• Influence of prenatal iron and zinc supplements on supplemental iron absorption, red blood cell iron incorporation, and iron status in pregnant Peruvian women.

  1999cited by this paper
• Perspectives in iron metabolism.

  1982cited by this paper
• Ferrokinetics: a biologic model for plasma iron exchange in man.

  1970cited by this paper

• Efficacy and safety of intravenous iron in patients with restless legs syndrome with normal serum ferritin levels: a stratified subanalysis

  2025cites this paper
• Efficacy and safety of iron supplements for restless leg syndrome, a systematic review, meta-analysis, meta-regression, and trial sequential analysis of randomized controlled trials

  2025cites this paper
• Rethinking clinical trials in restless legs syndrome: A roadmap.

  2024cites this paper
• Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients.

  2024cites this paper
• Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment

  2024cites this paper
• Restless legs syndrome is prevalent in adults with cystic fibrosis and impacts sleep quality.

  2023cites this paper
• Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.

  2023cites this paper
• Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.

  2022cites this paper
• Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?

  2022cites this paper
• Iron treatment of restless legs syndrome

  2022cites this paper
• Risk of Infection Associated With Administration of Intravenous Iron

  2021cites this paper
• Restless Sleep Disorder.

  2021cites this paper
• Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.

  2021cites this paper
• Adoption of Diffusion Tensor Imaging under Optimized Fuzzy C-Means Cluster Algorithm in Intracerebral Benign and Malignant Tumor Resection

  2021cites this paper
• Iron Replacement Therapy in Restless Legs Syndrome

  2020cites this paper
• Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.

  2020cites this paper
• Comparison between oral ferrous sulfate and intravenous ferric carboxymaltose in children with restless sleep disorder (RSD).

  2020cites this paper
• Idiopathic restless legs syndrome treatment: Progress and pitfalls?

  2019cites this paper
• Iron supplementation for restless legs syndrome - A systematic review and meta-analysis.

  2019cites this paper
• Relación entre hierro y síndrome de piernas inquietas

  2019cites this paper
• Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.

  2019cites this paper
• Restless Legs Syndrome and Other Movement Disorders of Sleep—Treatment Update

  2018cites this paper